Secretion of the incretin hormone glucagon-like-peptide 1 (GLP-1) from the intestinal L-cells play a significant role in improving glycaemic control following a meal (1) but it is rapidly inactivated by dipeptidylpeptidase-4 (DPP-4) (2) . Orally active DPP-4 inhibitor drugs are used to improve glycaemic control in people with diabetes. Several peptide component peptides from the edible seaweed Palmaria palmata (Dulse) have been identified as having DPP-4 inhibitory actions (3) . Here we examined the efficacy of three short synthetic peptides derived from Palmaria palmata to stabilise glucagon-like peptide-1(7-36)amide (GLP-1) using an in vitro HPLC assay and to affect insulin secretion and glycaemic control in mice challenged with an intraperitoneal glucose tolerance test (ipGTT).
